保健 - 第期 - page 12

12
防病之窗
ر
j࣬ኽʕ਷शषԣછʕːί
2007-2008
ϋྼ݄ٙΌ
਷ഐࣨष
ߗ
ᖹਿᇞሜ
ݟ
ٙഐ
؈
ᜑͪdʕ਷ഐࣨषɛ
ʕ
ߗ
εᖹ೯͛ଟ
މ
8.32%
dᐼ
މߒࠇ
12
ຬɛdᐼᅰඎ
සϣ׵Ι
ܓ
З֢˰
ޢ
ୋɚЗdЦ˰
ޢ
อ೯
ߗ
εᖹઃ
٫ɛᅰٙ
1/4
fᄿ
ߗع
ᖹ೯षଟ
މۆ
0.68%
dᐼ
ߒࠇ
Ϟ
1
ຬɛfவ݊ʕ਷ִ݁ୋɓϣʮක
ו
Ⴉίʕ਷ɽ௔೯
ତəᄿ
ߗع
ᖹഐࣨषɛf
ΌଢᇍఖlzdӊϋП
̈ତ
ڐ
5
ຬΤᄿ
ߗع
ᖹഐࣨष
ઃ٫iϾʕ਷ഐࣨष
ߗ
ᖹਿᇞሜ
ݟ
ᜑͪdΌ਷ഐࣨ
षઃ٫ʕᄿ
ߗع
ᖹଟ
މ
0.68
ĈdኽϤПၑᄿ
ߗع
ᖹഐ
ࣨषઃ٫Ϟ
ڐ
ຬɛf
͟׵ᄿ
ߗع
ᖹഐࣨष࿁఻˷
ה
ϞٙҤഐࣨɓᇞձɚ
ᇞᖹ
ي
ேପ͛
ߗ
ᖹ׌dΪϤdઃ٫ϥɳଟֻֻ
ܘ
৷fί
ڢی
ᖑ೯ٙɓৎᄿ
ߗع
ᖹഐࣨषԫ΁ʕd
53
Зઃ٫ʕϞ
52
ɛί೵೵ɧմlz޴ᘱ̘˰fί˰㠛ᐼ
฀ԫ௓ඹబ
ޜ
޶Ըdν
؈
ߗع
ᖹഐࣨषʔঐ੻Ց
છՓdɛᗳਗ਼஗੭ΫӚϞҤ͛९eࠦ࿁ഐࣨष఻˷
Ҽ˓ೌഄٙࣛ˾f¨Ϊ
މ
ɛᗳʊ຾
40
εϋӚϞ޼Ⴁ
̈อᖹəf©
結核病其實是可以治癒的
Ң਷㠛͛௅
௰ژ
อʮбٙʕ਷ഐࣨषԣ
ط
ٟึ൙ᄆ
؈
ᜑͪdҢ਷ʮ͏࿁ഐࣨषՈϞෂ
ݑ
׌ʿ̙˸
ط
ᓹٙႩٝ೻
ܓ
Эd࿁ഐࣨषԣ
ط
ዚ࿴ʿ౤Զе൬ൢ
ᓙձ
ط
ᐕٙٝወଟЭd࿁ഐࣨषઃ٫աٟึ؜ൖٙ
ዄː೻
৷ܓ
f
࠯΋dᒱ್৶ഐࣨe໘ᇫഐࣨഃʔՈϞෂ
ݑ
׌dШ
੬Ԉٙ٬ഐࣨٙɓԬᗳۨՈϞෂ
ݑ
׌f̥Ϟຈʕঐ
ݟ
̈ഐࣨ૖ഽٙ٬ഐࣨषɛʑՈϞෂ
ݑ
׌dவԬ
ઃ٫ίۗྔe͂ᄝᎾeɽᑊႭ༑ࣛdఌ
ث
ᄝՑ˼ɛ
ᑕɪఱ̙ঐிϓෂ
ݑ
f
ୋɚdৰˇᅰεᖹ
ߗ
ᖹ׌ഐࣨቋַʔฏ̮dഒɽε
ᅰഐࣨष̙݊˸
ط
ᓹٙfШც
੶ሜٙ݊dഐࣨष
͍ٙ஝࿏ֵ
ط
ᐕ̀඲ϞœЇŕ
˜ٙᐕ೻d˲ც
ε၇ᖹ
ي
ᑌΥԴ͜dʑঐ࿏ֵ
ط
ᓹf˰
ޢ
㠛͛ଡ଼
މ
Ϥ౤̈ٙତ˾ഐࣨषછՓഄଫ
Ӌઃ٫ӊϣ؂
ᖹѩ
ίᔼਕɛࡰࠦൖɨ؂͜f
ܘ
εઃ٫Ⴠൖषઋ
א
Ϊᖹ
ي
ਓЪ͜ӷІ৾ᖹdӚঐ੻Ց߅ኪ஝ᇍٙ
ط
ᐕd̙ঐኬ
ߗߧ
ᖹഽࣺٙପ͛dᄣ̋
ط
ᐕᗭ
ܓ
fୋ
ɧdҢ਷ጤॴձጤॴ˸ɪٙᔼᐕ㠛͛ዚ࿴d۬ᕄձ
̹۬ேணϞᏨ
طݟ
ᐕഐࣨषٙਖ਼
ژ
ዚ࿴d਷࢕е൬
މ
ݑ
׌٬ഐࣨઃ٫౤ԶҤഐࣨᖹۜձ˴
ݟ
f
މ
̋੶࿁Ό਷ഐࣨष
ޥ
ઋٙ၍ଣd
ڭ
ᗇઃ٫੻Ց߅
ኪ஝ᇍٙ
ط
ᐕdʕശɛ͏΍ձ਷ෂ
ݑ
षԣ
جط
‘
஝֛d٬ഐࣨઃ٫ʿဲЧઃ٫
ίഐࣨषԣ
ط
ዚ࿴
ආБ୕ɓٙᏨ
ݟ
eຖኬʷᐕձ၍ଣf
ܝ௰
d̥Ϟഐࣨ૖ഽຈ෩˪Ꮸ
ݟ
яජ׌ٙ٬ഐࣨઃ
٫ʑϞෂ
ݑ
׌f٬ഐࣨઃ٫ක֐ટա͍஝ᖹ
طي
ŏЇŐ
݋ಂ
ܝ
dɓছఱʔՈϞෂ
ݑ
׌d̙˸ਞ̋
͍੬ٟึ
ݺ
ਗfٟึᏐ࿁ഐࣨषઃ٫ഗʚᗫᕿձ๫
ᚥdʔᏐ༈؜ൖഐࣨषɛf
Beware: the Tuberculosis Killer is Back: Killing 2-3 Patients a Minute
Although tuberculosis (TB) was successfully eradicated in developed countries, it is still prevalent in developing countries, e.g.,
Cambodia. The current problem is development of drug resistance, especially as there are no new antibiotics for TB during the last 40
years. The worst is there is not only a phenomenon of mutual enhancement for TB and Aids but also masking the typical manifestation
of TB: the mortality of patients with dual affliction are very much higher. In China, 120,000 (8.32%) TB patients have resistance to >1
antibiotic: ranked second in the world; 10,000 (0.68%) have pan-resistance: responsible for 1/4 of the world’s total. As resistance is
associated with high mortality, ensure prompt active treatment; the WHO recommends taking all 4 antibiotics concurrently for at least
6 months to prevent resistance: Note also: (1) Only those with positive TB bacilli smears in their phlegm are contagious (2) Treatment
must last for 6-8 months, lest bacterial resistance develops (3) In China, there are well-organized and free investigation and treatment
facilities for TB. Above all, as TB patients are normally non-infectious after 2-3 weeks’ treatment, they should not be stigmatized.
1...,2,3,4,5,6,7,8,9,10,11 13,14,15,16,17,18,19,20,21,22,...84
Powered by FlippingBook